Admission Date:  [**2154-7-2**]              Discharge Date:   [**2154-7-6**]

Date of Birth:  [**2103-9-3**]             Sex:   M

Service: CARDIOTHORACIC

Allergies:
Erythromycin Base

Attending:[**First Name3 (LF) 1283**]
Chief Complaint:
Decrease exercise tolerance

Major Surgical or Invasive Procedure:
[**2154-7-3**] - Minimally Invasive Mitral Valve Repair (34mm [**Doctor Last Name 405**]
ring), PFO closure.


[**Last Name (NamePattern4) 15255**] of Present Illness:
The patient is a 50-year-old gentleman who was diagnosed with
severe mitral regurgitation. He has been followed by serial
echo's with the most recent showing 4+ MR. The patient was
referred to Dr. [**Last Name (Prefixes) **] for repair or replacement. The
patient understood the risks and benefits of the procedure
and wished to proceed.


Past Medical History:
MVP/MR
[**First Name (Titles) 15421**] [**Last Name (Titles) 33309**]
[**Last Name (Titles) **]
Pulmonary nodule on CT (Stable)

Social History:
Works in window treatments. 2 drinks weekly. Quit smoking 20
years ago. Lives with wife.

Family History:
Father with CAD

Physical Exam:
GEN: WDWN in NAD
SKIN: Warm, Dry, No C/C/E
HEENT: NCAT, PERRL, Anicteric sclera. Needs root canal
LUNGS: Clear
HEART: RRR, IV/VI holosystolic murmur
ABD: BEnign
EXT: No varicosities, pulses 2+, no edema

Pertinent Results:
[**2154-7-3**] ECHO
The ascending, transverse and descending thoracic aorta are
normal in diameter and free of atherosclerotic plaque. The
aortic valve leaflets (3)appear structurally normal with good
leaflet excursion and no aortic regurgitation. There is no
pericardial effusion.

[**2154-7-3**] CXR
Bibasilar atelectasis. No pulmonary edema.

[**2154-7-5**] 07:25AM BLOOD WBC-8.8 RBC-3.62* Hgb-11.4* Hct-32.4*
MCV-89 MCH-31.5 MCHC-35.2* RDW-13.4 Plt Ct-118*
[**2154-7-5**] 07:25AM BLOOD Plt Ct-118*
[**2154-7-5**] 07:25AM BLOOD Glucose-116* UreaN-12 Creat-0.8 Na-135
K-4.3 Cl-100 HCO3-26 AnGap-13

[**Last Name (NamePattern4) 4125**]ospital Course:
Mr. [**Known lastname 33310**] was admitted to the [**Hospital1 18**] on [**2154-7-2**] for elective
surgical management of his mitral valve disease. His surgery was
delayed one day due to a surgical emergency. He was taken to the
operating room on [**2154-7-3**] where he underwent a minimally invasive
mitral repair using a 34mm [**Doctor Last Name **] ring and patent foramen
ovale closure. Postoperatively he was taken to the cardiac
surgical intensive care unit for monitoring. He awoke
neurologically intact and was extubated. On postoperative day
one he was transferred to the cardiac surgical step down unit
for further recovery. Aspirin and beta blockade were started. He
was gently diuresed towards his preoperative weight. The
physical therapy service was consulted for assistance with his
postoperative strength and mobility. He continued to make steady
progress and was discharged home on postoperative three. He will
follow-up with Dr. [**Last Name (Prefixes) **], his cardiologist and his primary
care physician as an outpatient.

Medications on Admission:
Lisinopril 20mg QD
Advair
Clarinex


Discharge Medications:
1. Metoprolol Tartrate 25 mg Tablet Sig: One (1) Tablet PO BID
(2 times a day).
Disp:*60 Tablet(s)* Refills:*2*
2. Furosemide 20 mg Tablet Sig: One (1) Tablet PO twice a day
for 7 days.
Disp:*14 Tablet(s)* Refills:*0*
3. Potassium Chloride 10 mEq Capsule, Sustained Release Sig: Two
(2) Capsule, Sustained Release PO once a day for 7 days.
Disp:*14 Capsule, Sustained Release(s)* Refills:*0*
4. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2
times a day) for 10 days.
Disp:*20 Capsule(s)* Refills:*0*
5. Aspirin 81 mg Tablet, Delayed Release (E.C.) Sig: One (1)
Tablet, Delayed Release (E.C.) PO DAILY (Daily).
Disp:*30 Tablet, Delayed Release (E.C.)(s)* Refills:*2*
6. Hydromorphone 2 mg Tablet Sig: 1-2 Tablets PO Q3-4H (Every 3
to 4 Hours) as needed for 3 weeks.
Disp:*60 Tablet(s)* Refills:*0*
7. Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device Sig:
One (1) Disk with Device Inhalation [**Hospital1 **] (2 times a day).
Disp:*60 Disk with Device(s)* Refills:*2*
8. Lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Disp:*30 Tablet(s)* Refills:*2*


Discharge Disposition:
Home With Service

Facility:
[**Hospital3 **] VNA

Discharge Diagnosis:
MVP/MR
[**First Name (Titles) **]
[**Last Name (Titles) **]
Pulmonary nodule
s/p Root canal


Discharge Condition:
Good


Discharge Instructions:
1) Monitor wounds for signs of infection. These include redness,
drainage or increased pain.
2) Report any fever greater then 100.5.
3) Report any weight gain of 2 pounds in 24 hours or 5 pounds in
1 week.
4) You may wash you incision and pat dry. No swimming or bathing
until it has healed.
5) No lotions, creams or powders to wound until it has healed.


Followup Instructions:
Follow-up with Dr. [**Last Name (STitle) 1290**] in 1 month. ([**Telephone/Fax (1) 1504**]
Follow-up with cardiologist Dr. [**First Name (STitle) 437**] in [**1-28**] weeks.
Follow-up with primary care physician [**Last Name (NamePattern4) **]. [**Last Name (STitle) **] in 2 weeks.
([**Telephone/Fax (1) 33311**].
Call all providers for appointments.



Completed by:[**2154-8-15**]